Results 11 to 20 of about 118 (89)

A Clinical Study to Evaluate the Effect of Pathyadi Kwatha and Anu Taila Nasya in the Management of Ardhavbhedaka w.s.r. to Migraine

Ayushdhara
A rise in acute and chronic health issues is caused by the shifting demands of the workplace, especially in light of urbanization and contemporary lifestyles. A large percentage of people suffer from migraines, one of the most prevalent and debilitating chronic illnesses.
Chaudhary Vijay
exaly   +2 more sources

Clinical Evaluation of Efficacy of Mahatriphaladya Ghrita and Anu Taila Nasya in the Management of Computer Vision Syndrome

Journal of Research in Ayurvedic Sciences, 2018
Bhagwan Sharma, Bharti LNU, Nandini Jadhav, Shashi Vedi   +3 more
exaly   +2 more sources

Effectiveness of anu taila nasya combined with gokshura lepa in khalitya: An ayurvedic and contemporary review

International Journal of Advanced Academic Studies
Arvind Chaturvedi, Darshana .
exaly   +2 more sources

Standardization of Bindu Pramana for Nasya

Indian Journal of Ayurveda and Integrative Medicine KLEU, 2023
Introduction: Nasya (nasal administration of medication) is one of Dinacharya (daily regimen) mentioned by Acharyas. Two Bindu is considered the recommended dose of Pratimarsha Nasya (done as a part of daily regimen).
Aiswarya Balagopal, Bargale Sushant Sukumar   +1 more
doaj   +1 more source

Management of Badhirya (hearing impairment) through Ayurvedic approaches: A case report

Journal of Ayurveda Case Reports, 2021
Hearing impairment is a complete or partial loss of ability to hear from one or both ears. It can be congenital or acquired and the clinical features closely resemble to Badhirya explained in Ayurveda.
Shelly Tyagi, Narayan Bavalatti, Manjusha Rajagopala   +2 more
doaj   +1 more source

A case report on the management of lingual papilitis through Ayurveda

Journal of Ayurveda Case Reports, 2022
Transient lingual papilitis is a common inflammatory hyperplasia of one or multiple fungiform lingual papillae that has acute onset. It is painful and transient. Based on the clinical features, the condition can be compared with Pittaja jihvakantaka.
Narayan Bavalatti, Manjusha Rajagopala, Anjali Dabas   +2 more
doaj   +1 more source

Safe and effective management of COVID-19 through ayurveda intervention: A case series

Journal of Ayurveda, 2021
Introduction: COVID-19/SARS-CoV-2 has become a major concern for whole humanity, it is rising rapidly and the condition is worsening. With a huge transmission rate, it has become an important requirement of this times to hatch out a safe and effective ...
Santosh Kumar Bhatted, Kavita Kumari, Nishant Malhotra, Tanuja Nesari   +3 more
doaj   +1 more source

Anu taila, an herbal nasal drop, suppresses mucormycosis by regulating host TNF-α response and fungal ergosterol biosynthesis

Journal of Applied Microbiology, 2022
Abstract Aim The intractable, mucormycosis, caused by Mucorales primarily targets immunocompromised individuals. The first-line therapy, intravenous liposomal amphotericin B and surgical debridement of necrotic tissue, is contraindicative in individuals with compromised kidneys.
Acharya Balkrishna, Shubhangi Rastogi, Bhawana Kharayat, Meenu Tomer, Yash Varshney, Kanchan Singh, Priya Kumari, Rishabh Dev, Jyotish Srivastava, Swati Haldar, Anurag Varshney   +10 more
openaire   +2 more sources

Anu Taila, an herbal nasal-drop, delays spore germination in Cunninghamella bertholletiae by reducing cAMP-PKA dependent ROS in mucorale pathogen and extrinsic ROS in human host cells

Letters in Applied Microbiology, 2023
Abstract The rare, fastest-germinating, frequently invasive mucorale, Cunninghamella bertholletiae, is intractable due to its imprecise etiology. Cunninghamella bertholletiae spores can infect both immunocompromised and immunocompetent individuals to cause mucormycosis. Sub-optimal drug-susceptibility further limits its treatment options.
Acharya Balkrishna, Sohan Sengupta, Priya Kumari, Rishabh Dev, Swati Haldar, Anurag Varshney   +5 more
openaire   +2 more sources

“Role Of Dashamula Kwatha Nadi Sweda And Anu Taila Nasya In The Management Of Ardita

International Journal Of Medical Science And Clinical Invention, 2016
Background: Ardita (Facial paralysis) is very troublesome disease and about one in every 60 or 70 persons are affected by it. It adversely affects the most important functions of the mouth leading to difficulty in deglutition, mastication, closing of the mouth as well as closure of eyes etc.
Dr.Devender kaushik, Dr.Amarnath Shukla
openaire   +1 more source